MedTrace Logo

Effect of Probiotic Lactobacillus Reuteri in the Treatment of Mucositis and Periimplantitis

NCT03047291 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2020-03-30

No results posted yet for this study

Summary

Evaluate clinically and microbiologically the effect of the oral probiotic Lactobacillus reuteri Prodentis (PerioBalance®, Sunstar, Switzerland) on implants with mucositis or periimplantitis, as a coadjuvant treatment of mechanical therapy.

Conditions

Interventions

DRUG

Probiotic

30 probiotic tablets were given after the mechanical debridement of implants with mucositis and periimplantitis.

DEVICE

Placebo Oral Tablet

30 placebo tablets were given after the mechanical debridement of implants with mucositis and periimplantitis.

Sponsors & Collaborators

  • Universitat Internacional de Catalunya

    lead OTHER

Principal Investigators

  • Marta Galofré Mercadé · Universitat Internacional de Catalunya

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-01
Primary Completion
2017-03-01
Completion
2017-09-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03047291 on ClinicalTrials.gov